Supplementary Figure 1: MYCER protein expressed from the transgene can enhance

Similar documents
Supplementary Fig. 1. Schematic structure of TRAIP and RAP80. The prey line below TRAIP indicates bait and the two lines above RAP80 highlight the

Primers used for PCR of conductin, SGK1 and GAPDH have been described in (Dehner et al,

Supplementary Fig. 1 Proteomic analysis of ATR-interacting proteins. ATR, ARID1A and

Supplementary Figure 1

Supplementary Material

File name: Supplementary Information Description: Supplementary figures and supplementary tables. File name: Peer review file Description:

Supplementary Figure 1. Nature Structural & Molecular Biology: doi: /nsmb.3494

Supplementary Figure 1. Additional RNAi screen data

Supplementary Figure 1. Intracellular distribution of the EPE peptide. HeLa cells were serum-starved (16 h, 0.1%), and treated with EPE peptide,

Supplementary Figure 1 (related to Figure 1) a. SVEC cells stably expressing egfp tbid 2A BCL xl were analysed by Western blot for expression of egfp

Supplementary Figure 1: Overexpression of EBV-encoded proteins Western blot analysis of the expression levels of EBV-encoded latency III proteins in

Emanuela Tumini, Sonia Barroso, Carmen Pérez Calero and Andrés Aguilera

SUPPLEMENTARY INFORMATION

Coleman et al., Supplementary Figure 1

3 P p25. p43 p41 28 FADD. cflips. PE-Cy5 [Fluorescence intensity]

Supplementary Figure 1. Expressions of stem cell markers decreased in TRCs on 2D plastic. TRCs were cultured on plastic for 1, 3, 5, or 7 days,

Nature Structural & Molecular Biology: doi: /nsmb Supplementary Figure 1. Analyses of ECTRs by C-circle and T-circle assays.

Fig. S1 TGF RI inhibitor SB effectively blocks phosphorylation of Smad2 induced by TGF. FET cells were treated with TGF in the presence of

Supplemental Material

Supplementary Figure 1. TRIM9 does not affect AP-1, NF-AT or ISRE activity. (a,b) At 24h post-transfection with TRIM9 or vector and indicated

TRIM31 is recruited to mitochondria after infection with SeV.

Pre-made Reporter Lentivirus for p53 Signal Pathway

Supplementary Information

SUPPLEMENTARY FIGURES


Supplementary Information. ATM and MET kinases are synthetic lethal with. non-genotoxic activation of p53

Fig. S1. Effect of p120-catenin overexpression on the interaction of SCUBE2 with E-cadherin. The expression plasmid encoding FLAG.

ASPP1 Fw GGTTGGGAATCCACGTGTTG ASPP1 Rv GCCATATCTTGGAGCTCTGAGAG

Supplementary Materials

Chromatin immunoprecipitation (ChIP) ES and FACS-sorted GFP+/Flk1+ cells were fixed in 1% formaldehyde and sonicated until fragments of an average

Supplementary Figure 1. GST pull-down analysis of the interaction of GST-cIAP1 (A, B), GSTcIAP1

Sarker et al. Supplementary Material. Subcellular Fractionation

Supplementary Figure 1 Phosphorylated tau accumulates in Nrf2 (-/-) mice. Hippocampal tissues obtained from Nrf2 (-/-) (10 months old, 4 male; 2

SUPPLEMENTAL EXPERIMENTAL PROCEDURES

Breast cell lines with Combination Index (CI) and p53 mutation status

Supplementary Information

Supplementary Materials for

Regulation of transcription by the MLL2 complex and MLL complex-associated AKAP95

SUPPLEMENTARY INFORMATION

Supplementary Figure 1, Wiel et al

Total RNA was isolated using Trizol reagent (Invitrogen) and reverse transcribed using

SUPPLEMENTARY INFORMATION

Supplementary Table 1. Sequences for BTG2 and BRCA1 sirnas.

Supplementary Methods

T H E J O U R N A L O F C E L L B I O L O G Y

SUPPLEMENTARY INFORMATION

Supplementary information

SUPPLEMENTARY INFORMATION

Supplementary Figure 1

SUPPLEMENTARY INFORMATION

Nature Biotechnology: doi: /nbt Supplementary Figure 1

Supplementary Information (Aoki, K. et al., "Chromosomal instability by β-catenin/tcf transcription in APC or β-catenin mutant cells")

Supplementary Figure S1

Supplementary Figure 1. Localization of MST1 in RPE cells. Proliferating or ciliated HA- MST1 expressing RPE cells (see Fig. 5b for establishment of

A RRM1 H2AX DAPI. RRM1 H2AX DAPI Merge. Cont. sirna RRM1

Genetic screening for synthetic lethal partners of polynucleotide kinase/phosphatase: potential for targeting SHP-1 depleted cancers

Arrest-In Transfection Reagent Catalog numbers: ATR1740, ATR1741, ATR1742, ATR1743

Mammosphere formation assay. Mammosphere culture was performed as previously described (13,

IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity

SUPPLEMENTARY INFORMATION

Supplemental Table 1 Gene Symbol FDR corrected p-value PLOD1 CSRP2 PFKP ADFP ADM C10orf10 GPI LOX PLEKHA2 WIPF1

Transcriptional regulation of BRCA1 expression by a metabolic switch: Di, Fernandez, De Siervi, Longo, and Gardner. H3K4Me3

Supplementary Information: Materials and Methods. GST and GST-p53 were purified according to standard protocol after

Nature Biotechnology: doi: /nbt Supplementary Figure 1

Supplementary Materials

Executing T-REX in mammalian cells

Multiplex Fluorescence Assays for Adherence Cells without Trypsinization

Supplementary Materials for

Supplementary Figure 1. The Hsp70 acetylation level is related to the co-chaperone binding of Hsp70 under various stress conditions.

Product: Arrest-In TM Transfection Reagent for RNAi

Supplementary Fig. 1. (A) Working model. The pluripotency transcription factor OCT4

Thanasoula et al. - Fig. S1

Mock. Control. sirna1

Supplemental Materials and Methods

As a control to demonstrate that we could isolate PCR products that result from ligating

Nature Structural and Molecular Biology: doi: /nsmb Supplementary Figure 1. Validation of CDK9-inhibitor treatment.

Online Supplementary Information

Supplementary Materials for

Nature Structural & Molecular Biology: doi: /nsmb Supplementary Figure 1

Supplementary Information for: CRISPR/Cas9-based target validation. for p53-reactivating model compounds

cells (MLEC) that produce luciferase under the control of the PAI-1 promoter in response to

Nature Structural & Molecular Biology: doi: /nsmb Supplementary Figure 1

Supplementary Data. Flvcr1a TCTAAGGCCCAGTAGGACCC GGCCTCAACTGCCTGGGAGC AGAGGGCAACCTCGGTGTCC

Supplemental Information. DNp63 Inhibits Oxidative Stress-Induced Cell. Death, Including Ferroptosis, and Cooperates with

a. Increased active HPSE (50 kda) protein expression upon infection with multiple herpes viruses: bovine

Supplementary Figure 1. APP cleavage assay. HEK293 cells were transfected with various

Supplementary Figure 1, related to Figure 1. GAS5 is highly expressed in the cytoplasm of hescs, and positively correlates with pluripotency.

Supplementary Figure 1. IFN-γ induces TRC dormancy. a, IFN-γ induced dormancy

supplementary information

Supplementary Figure 1. Confirmation of sirna in PC3 and H1299 cells PC3 (a) and H1299 (b) cells were transfected with sirna oligonucleotides

Supplementary Figure 1. RAD51 and RAD51 paralogs are enriched spontaneously onto

kda

Supplementary Figure 1

Table 1. Primers, annealing temperatures, and product sizes for PCR amplification.

HPV E6 oncoprotein targets histone methyltransferases for modulating specific. Chih-Hung Hsu, Kai-Lin Peng, Hua-Ci Jhang, Chia-Hui Lin, Shwu-Yuan Wu,

Supporting Information

SUPPLEMENTARY INFORMATION

Supplementary information; Mungamuri et al., 2006

(a) Immunoblotting to show the migration position of Flag-tagged MAVS

Supplementary Fig. 1 related to Fig. 1 Clinical relevance of lncrna candidate

Transcription:

Relative luciferase activity Relative luciferase activity MYC is a critical target FBXW7 MYC Supplementary is a critical Figures target 1-7. FBXW7 Supplementary Material A E-box sequences 1 2 3 4 5 6 HSV-TK Luc+ B Relative MYC reporter activity in uninfected MCF10A cells 4 Relative MYC reporter activity in MYCER-infected MCF10A cells 4 3.5 3.5 3 3 2.5 2.5 2 2 1.5 1.5 1 1 0.5 0.5 0 NT + 4OHT 0 NT + 4OHT Supplementary Figure 1: MYCER protein expressed from the transgene can enhance transcriptional activity. (A) A reporter plasmid containing 6 E-box sequences (CACGTG) followed Supplementary by a luciferase Figure 1. reporter MYCER was protein transfected expressed into from uninfected the transgene parental can MCF10A enhance or transcriptional activity. (A) A reporter plasmid containing 6 E-box sequences (CACGTG) MCF10A-MYCER cells and luminescence was measured 48 hr after transfection. (B) followed by a luciferase reporter was transfected into uninfected parental MCF10A or Luciferase activity from the reporter was normalized to Renilla luciferase activity. Each MCF10A-MYCER cells and luminescence was measured 48 hr after transfection. (B) experiment was done in triplicate and graphs show the average 3 biological replicates. Luciferase activity from the reporter was normalized to Renilla luciferase activity. Each Error experiment bars represent was done the in SEM. triplicate and graphs show the average 3 biological replicates. Error bars represent the SEM. 1

Asynchronous cells After double thymidine block 24h post release from DT block Supplementary Supplementary Figure Figure 2: 2. MCF10A-MYCER cells cells arrest arrest at the at G1/S the transition G1/S transition following following double double thymidine block. MCF10A-MYCER cells cells were were subjected subjected to two rounds to two rounds 2.5mM 2.5mM thymidine treatment, treatment, then fixed then and fixed stained and stained propidium iodide propidium flow cytometric iodide flow analysis. Compared to untreated asynchronous cells, thymidine treated cells showed cytometric analysis. Compared to untreated asynchronous cells, thymidine treated cells accumulation cells in M1+M2 (<2N DNA content). 24h after release, the cell cycle showed distribution accumulation returns to normal. cells in M1+M2 (<2N DNA content). 24h after release, the cell cycle distribution returns to normal. 2

MCF10A-MYCER TAM MCF10A-MYCER TAM -shrna +EtOH (MYC OFF) 50% GFP or RFP +4OHT (MYC ON) FACS analysis FACS analysis FACS analysis Supplementary Figure 3: Schematic fluorescence-based competition assay. Uninfected MCF10A-MYCER cells which express no fluorescent proteins are plated on the same plate MCF10A-MYCER cells infected a single shrna clone choice coexpressing GFP or RFP. At day 1, cells from the plate are subjected to live cell flow cytometry to verify ~50% fluorescence. Subsequently, the cells are split into control or 4OHT treated groups, and passaged every 48-72 hr. At each passage or desired timepoint, remaining fluorescence on the plate is measured by flow cytometry the duration the experiment. Supplementary Figure 3. Schematic fluorescence-based competition assay. Uninfected MCF10A-MYCER cells which express no fluorescent proteins are plated on the same plate MCF10A-MYCER cells infected a single shrna clone choice co-expressing GFP or RFP. At day 1, cells from the plate are subjected to live cell flow cytometry to verify ~50% fluorescence. Subsequently, the cells are split into control or 4OHT treated groups, and passaged every 48-72 hr. At each passage or desired timepoint, remaining fluorescence on the plate is measured by flow cytometry the duration the experiment. 3

WHOLE CELL EXTRACTS 4OHT - + - + MYCER c-jun Notch1 Cyclin E mtor βactin -130-95 -55-36 -130-95 -72-55 -300-55 -36 Supplementary Supplementary Figure 4. FBXW7 Figure 4: knockdown FBXW7 knockdown specifically leads specifically to stabilization leads to stabilization MYCER. MCF10A-MYCER MYCER. cells MCF10A-MYCER expressing either cells control expressing or FBXW7 either shrna control were or cultured FBXW7 in the shrna were presence cultured or absence in the 4OHT presence 4 or weeks. absence Whole 4OHT cell lysates 4 weeks. (80µg total Whole protein/lane) cell lysates were (80μg total run on SDS-PAGE protein/lane) and were subjected run on to SDS-PAGE Western blot and analysis subjected to major Western FBXW7 blot targets. analysis major Figure shows FBXW7 a representative targets. Figure image shows replicated a representative experiments. image replicated experiments. 4

Supplementary Figure 5. FBXW7 knockdown leads to preferential stabilization MYCER. MCF10A-MYCER cells stably expressing Dox-inducible shrna clones FBXW7 were treated or out 4OHT (MYC OFF or ON) 4 weeks, then cell lysates were analyzed by SDS-PAGE/Western blot. Bands were quantified using ImageQuant v5.2 (Molecular Dynamics) and normalized to loading controls. Figure shows averages from 3 independent biological replicates. Supplementary Figure 5: FBXW7 knockdown leads to preferential stabilization MYCER. MCF10A-MYCER cells stably expressing Dox-inducible shrna clones FBXW7 were treated or out 4OHT (MYC OFF or ON) 4 weeks, then cell lysates were analyzed by SDS-PAGE/Western blot. Bands were quantified using ImageQuant v5.2 (Molecular Dynamics) and normalized to loading controls. Figure shows averages from 3 independent biological replicates. 5

A B DNA DAMAGE APOPTOSIS 4OHT - + - + P-Chk2-72 4OHT - + - + Cleaved Caspase3-28 β actin Cleaved PARP1-95 P-H2AX -28 PUMA -28 HistoneH3 β actin Supplementary Figure 6: Long term FBXW7 knockdown and MYCER activation do not result in significant levels DNA damage or apoptosis. (A) Control or FBXW7 knockdown Supplementary cells Figure were 6. treated Long term FBXW7 or out knockdown 4OHT and MYCER 4 weeks activation and probed do not result the in significant levels DNA damage or apoptosis. (a) Control or FBXW7 knockdown cells presence were treated phosphorylated or out 4OHT Chk2 (in 4 weeks whole and cell probed lysate) or the H2AX presence (in chromatin-bound samples phosphorylated after fractionation) Chk2 (in whole as cell markers lysate) or H2AX checkpoint (in chromatin-bound activation/dna samples damage. after shfbxw7 fractionation) cells as did markers not show checkpoint a significant activation/dna accumulation damage. shfbxw7 either species cells did after not show long term treatment a significant accumulation 4OHT. (B) Similarly either species treated after cells long term were treatment probed 4OHT. the presence (b) Similarly treated cells were probed the presence apoptosis markers in whole cell lysates. apoptosis However, markers we failed in to whole detect any cell significant lysates. However, levels cleaved we failed caspase-3, to detect PARP1, any or significant PUMA in levels the surviving cleaved cells caspase-3, after 4 weeks PARP1, treatment. or PUMA Shown in above the surviving are representative cells after images 4 weeks 3 treatment. independent Shown replicates. above are representative images 3 independent replicates. 6

shcontrol shfbxw7-7 MYC OFF MYC ON Supplementary Figure 7: FBXW7 knockdown MYCER activation causes synergistic accumulation Supplementary Figure cells 7. in FBXW7 S and knockdown G2/M phase. MYCER MCF10A-MYCER activation causes cells synergistic stably expressing accumulation cells in S and G2/M phase. MCF10A-MYCER cells stably expressing control or FBXW7 shrna were cultured 4 weeks in the presence or absence control or FBXW7 shrna were cultured 4 weeks in the presence or absence 4OHT 4OHT (MYC OFF (MYC or ON). OFF Cells or ON). were fixed Cells and were stained fixed and propidium stained iodide propidium flow cytometric iodide flow cytometric analysis. Cells analysis. accumulate Cells in accumulate the M3+M4 region in the (<1N M3+M4 DNA content) region only (<1N in the DNA FBXW7 content) only in the knockdown FBXW7 and knockdown MYC ON condition. and MYC Shown ON is condition. a representative Shown image is a representative 3 independent image 3 independent replicates. replicates. 7

Supplementary Table 1: List top 78 synthetic lethal targets from MCF10A-MYCER screen. Results were filtered according to fold change (Log2 FC<-1) signal abundance between MYC ON and MYC OFF, and individually associated p-values (p<0.05). Only annotated target genes are shown. Candidates are ranked in order most depleted in the MYC ON population compared to MYC OFF (Log2 FC value). Rank Name p- value Log2 FC Acc. Number shrnai ID 1 ARL5B 0.0500-2.7089 NM_178815 v2hs_118631 2 C2orf44 0.0100-2.5672 NM_025203 v2hs_137381 3 TTBK1 0.0300-2.4316 AB058758 v2hs_238991 4 PSG6 0.0400-2.3989 NM_002782 v2hs_170657 5 NAT9 0.0500-2.3896 NM_015654 v2hs_263964 6 TRPM6 0.0300-2.1357 NM_017662 v2hs_155076 7 MFN2 0.0100-2.0827 NM_014874 v2hs_95806 8 C18orf54 0.0100-1.8569 NM_173529 v2hs_160761 9 DONSON 0.0300-1.8499 NM_017613 v2hs_154816 10 ZNF614 0.0400-1.8499 NM_025040 v2hs_235983 11 H2AFV 0.0100-1.8450 NM_138635 v2hs_200741 12 NUPL1 0.0500-1.8381 NM_014778 v2hs_233311 13 ZNF691 0.0100-1.7257 NM_015911 v2hs_236174 14 PSMD2 0.0500-1.7213 NM_002808 v2hs_219275 15 CDC14B 0.0400-1.7209 NM_033331 v2hs_203260 16 UGT1A1 0.0300-1.6796 NM_000463 v2hs_93183 17 SOX15 0.0500-1.6110 NM_006942 v2hs_229072 18 NUPL2 0.0500-1.6086 NM_007342 v2hs_86275 19 ANKRD27 0.0500-1.6068 NM_032139 v2hs_117932 20 EPHA7 0.0100-1.5984 NM_004440 v2hs_17738 21 ST8SIA4 0.0500-1.5098 NM_005668 v2hs_238967 22 SLC44A2 0.0500-1.4952 NM_020428 v2hs_72471 23 SH3BP4 0.0300-1.4934 NM_014521 v2hs_86832 24 KIAA0509 0.0300-1.4922 AB007978 v2hs_259524 25 DMKN 0.0500-1.4804 NM_033317 v2hs_160312 26 STK17A 0.0100-1.4726 NM_004760 v2hs_36021 27 PHF21A 0.0100-1.4564 NM_016621 v2hs_135309 28 EYA2 0.0200-1.4531 NM_005244 v2hs_43093 29 C6orf184 0.0100-1.4413 XM_168053 v2hs_121031 30 ZFYVE9 0.0100-1.4407 NM_004799 v2hs_35331 31 LRCH3 0.0400-1.4395 NM_032773 v2hs_222832 32 NR2E1 0.0100-1.4308 NM_003269 v2hs_261941 33 TOP3B 0.0100-1.4280 NM_003935 v2hs_47174 34 WDSOF1 0.0300-1.4122 NM_015420 v2hs_229697 35 CLDN5 0.0500-1.3596 NM_003277 v2hs_171412 36 CMTM2 0.0400-1.3528 NM_144673 v2hs_17530 37 IRAK1 0.0300-1.3447 NM_001569 v2hs_132369 8

38 APOBEC3A 0.0300-1.3348 NM_145699 v2hs_286556 39 ERGIC1 0.0300-1.3258 NM_020462 v2hs_71567 40 PARP15 0.0100-1.3206 NM_152615 v2hs_44475 41 RAE1 0.0500-1.2995 NM_003610 v2hs_27966 42 LEPREL1 0.0500-1.2897 NM_018192 v2hs_156224 43 ZNF132 0.0300-1.2802 NM_003433 v2hs_172208 44 SLC7A1 0.0500-1.2710 NM_003045 v2hs_153014 45 LAMA2 0.0200-1.2692 NM_000426 v2hs_92966 46 LOC344065 0.0400-1.2685 XM_292895 v2hs_143532 47 ATP1B1P1 0.0500-1.2641 NG_001081 v2hs_169198 48 C1orf182 0.0500-1.2536 NM_144627 v2hs_18680 49 KRIT1 0.0400-1.2463 NM_004912 v2hs_62790 50 ASAH3 0.0400-1.2436 NM_133492 v2hs_99964 51 OLFR89 0.0300-1.2192 AJ132194 v2hs_18007 52 CCDC25 0.0300-1.1758 NM_018246 v2hs_156496 53 TOP3A 0.0100-1.1740 NM_004618 v2hs_42272 54 MATK 0.0200-1.1567 NM_002378 v2hs_203423 55 ST14 0.0100-1.1516 NM_021978 v2hs_228778 56 KIAA0574 0.0300-1.1513 AB011146 v2hs_130193 57 PERP 0.0200-1.1513 NM_022121 v2hs_216968 58 FBXW7 0.0200-1.1469 AY033553 v2hs_89326 59 APOA2 0.0100-1.1369 NM_001643 v2hs_132594 60 C5 0.0400-1.1342 NM_001735 v2hs_150150 61 SLC36A4 0.0500-1.1260 NM_152313 v2hs_25433 62 PPP3CC 0.0300-1.1253 NM_005605 v2hs_57300 63 TRIM26 0.0500-1.1229 NM_003449 v2hs_172289 64 ELL 0.0500-1.1181 NM_006532 v2hs_198413 65 PRMT8 0.0100-1.1163 NM_019854 v2hs_34353 66 PRSS21 0.0500-1.1146 NM_006799 v2hs_83969 67 UBE2I 0.0200-1.0971 NM_003345 v2hs_171781 68 QRSL1 0.0400-1.0967 XM_301163 v2hs_49076 69 C11orf48 0.0400-1.0951 NM_024099 v2hs_116419 70 EPYC 0.0400-1.0697 NM_004950 v2hs_61963 71 TNFAIP2 0.0100-1.0598 NM_006291 v2hs_56492 72 PAQR3 0.0300-1.0499 NM_177453 v2hs_211154 73 PREB 0.0500-1.0457 NM_013388 v2hs_64102 74 CEND1 0.0300-1.0194 NM_016564 v2hs_135015 75 BBOX1 0.0300-1.0107 NM_003986 v2hs_246341 76 CDKL5 0.0500-1.0097 NM_003159 v2hs_262311 77 CMTM7 0.0100-1.0049 NM_138410 v2hs_70332 78 GCN1L1 0.0400-1.0020 XM_045792 v2hs_68924 9